Clinical Trial Update: Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update from Mayo Clinic evaluating a viral therapy for refractory liver cancer and other advanced solid tumors. The study (NCT01628640) status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Malignant Solid Neoplasm, Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED